- Home
- QTRX vs RCKT Comparison
QTRX vs RCKT Comparison
Compare QTRX & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QTRX | RCKT |
|---|---|---|
| Founded | 2007 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 337.7M | 340.9M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | QTRX | RCKT |
|---|---|---|
| Price | $7.63 | $3.32 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 14 |
| Target Price | $10.33 | ★ $29.12 |
| AVG Volume (30 Days) | 875.4K | ★ 2.0M |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $130,203,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $28.28 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.05 | $2.19 |
| 52 Week High | $12.94 | $15.00 |
Technical Indicators
Market Signals| Indicator | QTRX | RCKT |
|---|---|---|
| Relative Strength Index (RSI) | 71.38 | 51.21 |
| Support Level | $6.70 | $3.08 |
| Resistance Level | $7.89 | $3.45 |
| Average True Range (ATR) | 0.46 | 0.18 |
| MACD | 0.14 | 0.05 |
| Stochastic Oscillator | 89.45 | 75.00 |
Price Performance
Historical ComparisonAbout QTRX Quanterix Corporation
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.